SELENBP1 expression is associated with poor prognosis in several cancer types, including lung adenocarcinoma, hepatocellular carcinoma, and colorectal carcinogenesis, as well as breast cancer [55,56,57,58]. This evidence concerns the gene SELENBP1 and breast cancer.